Nucleic Acid Isolation & Purification Market to Reach US$ 9.77 Billion by 2030 at 9.6% CAGR, Led by North America's 39% Share and Key Players Thermo Fisher, Danaher & Illumina

The Global Nucleic Acid Isolation & Purification Market was valued at US$ 5.75 billion in 2024 and is projected to reach US$ 9.77 billion by 2030, expanding at a CAGR of 9.6% during 2025-2030. Multiple independent market studies indicate similar growth momentum, with some projections suggesting the market may surpass US$ 12 billion by 2033. The strong demand is driven by rising applications in molecular diagnostics, genetic testing, oncology, personalized medicine, and large-scale genomic research.

In terms of market position, kits and reagents continue to dominate the product landscape due to high repeat usage and widespread adoption. Magnetic bead-based isolation technologies are expanding rapidly because of their automation compatibility, scalability, and high yield. By application, clinical diagnostics holds the largest share, supported by increased demand for PCR, NGS workflows, and infectious disease testing. Regionally, North America leads the market with more than 39% share due to strong R&D investments, while Asia-Pacific stands out as the fastest-growing region driven by expanding biotechnology and healthcare infrastructure.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/nucleic-acid-isolation-and-purification-market?sai-v

Nucleic Acid Isolation & Purification Market refers to the industry that provides tools, reagents, and systems used to extract and purify DNA and RNA from biological samples for research, diagnostics, and biopharmaceutical applications.

Key Developments

United States
✅ August 2025: U.S. biotechnology companies expanded production of rapid nucleic acid extraction kits designed for point-of-care infectious disease testing, improving turnaround time for clinical labs.

✅ June 2025: American research labs adopted advanced magnetic bead-based purification systems that offer higher yield and improved reproducibility for genomics and oncology workflows.

✅ March 2025: U.S. diagnostic manufacturers introduced automated high-throughput nucleic acid purification platforms targeted at large hospitals and genetic testing centers.

Japan
✅ September 2025: Japanese life science companies launched next-generation RNA purification kits optimized for stability and accuracy in gene expression and mRNA therapeutic research.

✅ June 2025: Japan's clinical laboratories expanded use of automated nucleic acid isolation systems integrated with robotic liquid-handling units to support growing molecular diagnostics demand.

✅ February 2025: Research institutions in Japan developed ultra-pure extraction reagents enabling improved sensitivity for PCR, NGS, and CRISPR-related applications.

Mergers & Acquisitions

United States
✅ April 2025: A leading U.S. molecular diagnostics company acquired a nucleic acid purification technology startup specializing in high-yield magnetic nanoparticle extraction systems.

Japan
✅ March 2025: A Japanese biotech manufacturer partnered with a domestic reagent company to co-develop next-generation DNA and RNA extraction kits for clinical and research markets.

✅ January 2025: A Japan-based molecular biology tools provider collaborated with a U.S. genomics firm to expand distribution of advanced nucleic acid purification products in North America and APAC.

Key Players
MP Biomedicals | Illumina, Inc. | General Electric Company | Sigma-Aldrich | F. Hoffmann-La Roche AG | Bio-Rad Laboratories | Promega Corporation | Danaher Corporation | Agilent Technologies | Thermo Fisher Scientific

Key Highlights
• Thermo Fisher Scientific - Holds 15.2% share of the global molecular biology and life science tools market, driven by its comprehensive portfolio of reagents, consumables, genomic analysis tools, and laboratory instruments.

• Danaher Corporation - Accounts for 13.9% share, supported by strong demand for its diagnostics, life sciences instrumentation, and biotechnology research solutions.

• Illumina, Inc. - Maintains 12.4% share, primarily driven by leadership in next-generation sequencing (NGS) platforms and genomic analysis technologies.

• F. Hoffmann-La Roche AG - Holds 10.8% share, backed by advanced PCR technologies, diagnostics platforms, and molecular testing solutions.

• Agilent Technologies - Contributes 9.7% share, supported by chromatography systems, molecular biology reagents, and analytical instrumentation.

• Bio-Rad Laboratories - Holds 8.5% share, driven by strong adoption of its PCR systems, electrophoresis tools, and molecular diagnostic consumables.

• Sigma-Aldrich (now part of Merck KGaA) - Accounts for 7.4% share, benefiting from its wide offering of reagents, chemicals, and molecular biology kits.

• Promega Corporation - Holds 6.3% share, supported by its enzymology tools, DNA amplification technologies, and molecular assay kits.

• General Electric Company - Maintains 5.1% share, leveraging its legacy life sciences instrumentation and analytical solutions (GE Healthcare Life Sciences, now Cytiva under Danaher).

• MP Biomedicals - Contributes 4.2% share, recognized for molecular biology reagents, nucleic acid purification systems, and life science research products.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=nucleic-acid-isolation-and-purification-market?sai-v
(Purchase 2 or more Reports and get 50% Discount)

Market Drivers

• Growing use of nucleic acid-based diagnostics in infectious disease testing, oncology, and genetic screening is increasing adoption of advanced isolation and purification kits.

• Expansion of precision medicine and personalized therapies is boosting demand for high-purity DNA and RNA extraction technologies.

• Rising investments in genomics, transcriptomics, and proteomics research are driving growth in laboratories, biotechnology firms, and academic institutes.

• Rapid growth of molecular point-of-care testing is creating strong demand for automated, user-friendly extraction platforms.

• Increasing adoption of next-generation sequencing (NGS) and digital PCR workflows requires high-quality nucleic acid samples, accelerating market expansion.

Industry Developments
• September 2025 (US): Biotech companies launched next-generation magnetic bead-based extraction kits optimized for high sensitivity in infectious disease testing.

• July 2025 (Germany): Automation firms introduced fully integrated nucleic acid purification workstations designed for high-throughput clinical laboratories.

• May 2025 (Japan): Manufacturers unveiled microfluidic-based extraction systems enabling rapid DNA and RNA purification for point-of-care diagnostics.

• March 2025 (UK): Collaborations between sequencing companies and reagent suppliers expanded development of extraction kits compatible with ultra-high-throughput NGS workflows.

Regional Insights
• North America - 38% share: Growth is driven by "high adoption of molecular diagnostics, strong investment in genomics research, and widespread use of automated purification technologies in clinical and research laboratories."

• Europe - 30% share: Expansion is supported by "well-established biotechnology research infrastructure, rising adoption of NGS workflows, and increasing demand for high-quality nucleic acids in clinical diagnostics."

• Asia Pacific - 26% share: Growth is fueled by "rapid expansion of molecular testing, increasing biomedical research funding, and strong growth in pharmaceutical and biotechnology manufacturing."

• Latin America - 4% share: Demand is rising due to "increasing adoption of PCR-based diagnostics, improving laboratory infrastructure, and rising investments in public health testing programs."

• Middle East & Africa - 2% share: Growth is supported by "expansion of clinical molecular testing, rising infectious disease screening, and growing investment in modern laboratory facilities."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/nucleic-acid-isolation-and-purification-market?sai-v

Key Segments

➥ By Product Type
Kits hold the leading share as they offer ready-to-use, standardized protocols that simplify nucleic acid isolation and ensure consistent results across laboratories. They are widely used in routine research, diagnostics, and high-throughput workflows.

Reagents remain essential for laboratories that require flexibility to optimize or customize extraction processes for different sample types.
Instruments include automated extractors and purification systems designed to increase throughput, reduce manual intervention, and improve reproducibility, especially in clinical and industrial settings.

➥ By Technology
Reagent-based isolation and purification continues to dominate due to its broad compatibility with multiple sample types and its ability to yield high-quality nucleic acids for downstream applications.Column-based isolation and purification is widely adopted for its simplicity, speed, and ability to provide clean extracts suitable for molecular biology workflows.Magnetic bead-based isolation and purification is growing rapidly as it enables automation, high-throughput processing, and higher recovery efficiency, making it ideal for clinical diagnostics and genomic research.Other technologies, including precipitation methods and microfluidics-based techniques, serve specialized applications requiring unique separation or low-input processing.

➥ By End Users
Academic and government research institutes lead usage as they conduct extensive molecular biology, genomics, and biomedical research requiring routine nucleic acid extraction.Pharmaceutical and biotechnology companies rely on these products for drug discovery, vaccine development, cell and gene therapy workflows, and biomarker research.Contract research organizations (CROs) use extraction technologies to support outsourced analytical, clinical, and preclinical studies.Hospitals and diagnostic centers use nucleic acid isolation for PCR testing, infectious disease detection, cancer diagnostics, and personalized medicine workflows.Others, including forensic labs, food testing labs, and environmental testing centers, utilize extraction tools for specialized analytical applications.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.